I wonder ..
What if the T1 diagnostics company is none other than
Jannsen?
What if they just waiting for the Glifozin Study to be completed and confirmed successful and then take exclusive ownership of PD or even buy PIQ out?
The current market valuation for PIQ is peanuts, The PromarkerD test has the ability to generate potentially significant revenues for many many years.
Here’s an interesting video from Jannsens Diagnostics arm - I can’t help but feel subtle mentions to PIQ in this..
Ann: PromarkerD latest results published in peer reviewed journal, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
-0.020(6.15%) |
Mkt cap ! $49.87M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.5¢ | 28.5¢ | $201.7K | 642.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3253 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 57411 | 2 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |